Letter to FDA re: Adverse event reporting
![Letter to FDA re: Adverse Event Reporting image](/sites/default/files/styles/700x530/public/2022-02/fdalogo.png.webp?itok=6be38-7h)
Wikimedia.org.
CSPI writes to draw FDA’s attention to our new publication in the journal Annals of Allergy, Asthma, & Immunology titled “Adverse Events and Labeling Issues Related to Suspected Sesame Allergy Reported in an Online Survey.” This study adds to the body of literature documenting under-reporting of adverse events related to foods to FDA. We request a meeting with the Center for Food Safety and Applied Nutrition (CFSAN) to discuss our findings and, more generally, our recommendations for an improved adverse event reporting system.